İmplante Edilebilir Kardiyoverter Defibrilatör (ICD) Mevcut Hastalarda Uygun Cihaz Şoklarının Yönetimi

Knops RE, Olde Nordkamp LRA, Delnoy P-PHM, et al. Subcutaneous or transvenous defibrillator therapy (PRAETORIAN trial). N Engl J Med 2020; 383:526–36. doi: 10.1056/NEJMoa1915932.

Katja Zeppenfeld, Jacob Tfelt-Hansen, Marta de Riva, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC) European Heart Journal, Volume 43, Issue 40, Pages 3997–4126 doi: 10.1093/eurheartj/ehac262

Theresa A McDonagh, Marco Metra, Marianna Adamo, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, Volume 42, Issue 36, Pages 3599–3726 doi: 10.1093/eurheartj/ehab368

Ihab Elsokkari , Yukiomi Tsuji, John L Sapp, et al. Recent Insights Into Mechanisms and Clinical Approaches to Electrical Storm. Can J Cardiol 2022 Apr;38(4): 439-453. doi: 10.1016/j.cjca.2021.12.015

Franz-Josef Neumann, Miguel Sousa-Uva, Anders Ahlsson, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, Volume 40, Issue 2, Pages 87–165 doi: 10.1093/eurheartj/ehy394.

Amira Assaf, Roberto Diletti, Mark G. Hoogendijk, et al. Vulnerability for ventricular arrhythmias in patients with chronic coronary total occlusion. Expert Review of Cardiovascular Therapy. 2020 Aug;18(8):487-494. doi: 10.1080/14779072.2020.1793671

Gasparini M, Menozzi C, Proclemer A, et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischemic cardiomyopathy implanted for primary prevention: The RELEVANT study. Eur Heart J 2009; 30(22):2758-2767. doi: 10.1093/eurheartj/ehp247

Alessandro Proclemer, Emanuela T Locati. The MADIT-RIT study. G Ital Cardiol (Rome) 2013 Apr;14(4): 241-5. doi: 10.1714/1257.13877

Bindi K. Shah, MD. Optimal Implantable Cardioverter Defibrillator Programming (Review article). Cardiology in Review 2017;25: 30–35 doi: 10.1097/CRD.0000000000000133.

Pacifico A, Hohnloser SH, Williams JH, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d, l-Sotalol Implantable Cardioverter Defibrillator Study Group. N Engl J Med 1999;340: 1855–62. doi: 10.1056/NEJM199906173402402.

Dorian P, Borggrefe M, Al-Khalidi HR, et al. Placebo controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004;110: 3646–54. doi: 10.1161/01.CIR.0000149240.98971.A8

Ángel Arenal , Pablo Ávila , Javier Jiménez-Candil, et al. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia J Am Coll Cardiol 2022 Apr 19;79(15):1441-1453. doi: 10.1016/j.jacc.2022.01.050

Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26): 2657–65. doi: 10.1056/NEJMoa065457

Amir AbdelWahab , John Sapp. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. Curr Cardiol Rep 2017 Sep 13;19(11):105 doi: 10.1007/s11886-017-0924-0

F. Streitner, J. Kuschyk, C. Dietrich, et al. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention. Clin Cardiol, 34(10); (2011): 604-609 doi: 10.1002/clc.20949

Ihab Elsokkari, John L. Sapp. Electrical storm: Prognosis and management. Progress in Cardiovascular Diseases Volume 66, May–June 2021, Pages 70-79. doi: 10.1016/j.pcad.2021.06.007

Ahmed AlTurkia, Riccardo Proiettib, Vincenzo Russoc, et al. Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients. Pharmacological Research 2019 May;143: 133-142 doi: 10.1016/j.phrs.2019.03.020

Knops RE, Olde Nordkamp LRA, Delnoy P-PHM, et al. Subcutaneous or transvenous defibrillator therapy (PRAETORIAN trial). N Engl J Med 2020; 383:526–36. doi: 10.1056/NEJMoa1915932.

Katja Zeppenfeld, Jacob Tfelt-Hansen, Marta de Riva, et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: Developed by the task force for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death of the European Society of Cardiology (ESC) Endorsed by the Association for European Paediatric and Congenital Cardiology (AEPC) European Heart Journal, Volume 43, Issue 40, Pages 3997–4126 doi: 10.1093/eurheartj/ehac262

Theresa A McDonagh, Marco Metra, Marianna Adamo, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC. European Heart Journal, Volume 42, Issue 36, Pages 3599–3726 doi: 10.1093/eurheartj/ehab368

Ihab Elsokkari , Yukiomi Tsuji, John L Sapp, et al. Recent Insights Into Mechanisms and Clinical Approaches to Electrical Storm. Can J Cardiol 2022 Apr;38(4): 439-453. doi: 10.1016/j.cjca.2021.12.015

Franz-Josef Neumann, Miguel Sousa-Uva, Anders Ahlsson, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Heart Journal, Volume 40, Issue 2, Pages 87–165 doi: 10.1093/eurheartj/ehy394.

Amira Assaf, Roberto Diletti, Mark G. Hoogendijk, et al. Vulnerability for ventricular arrhythmias in patients with chronic coronary total occlusion. Expert Review of Cardiovascular Therapy. 2020 Aug;18(8):487-494. doi: 10.1080/14779072.2020.1793671

Gasparini M, Menozzi C, Proclemer A, et al. A simplified biventricular defibrillator with fixed long detection intervals reduces implantable cardioverter defibrillator (ICD) interventions and heart failure hospitalizations in patients with non-ischemic cardiomyopathy implanted for primary prevention: The RELEVANT study. Eur Heart J 2009; 30(22):2758-2767. doi: 10.1093/eurheartj/ehp247

Alessandro Proclemer, Emanuela T Locati. The MADIT-RIT study. G Ital Cardiol (Rome) 2013 Apr;14(4): 241-5. doi: 10.1714/1257.13877

Bindi K. Shah, MD. Optimal Implantable Cardioverter Defibrillator Programming (Review article). Cardiology in Review 2017;25: 30–35 doi: 10.1097/CRD.0000000000000133.

Pacifico A, Hohnloser SH, Williams JH, et al. Prevention of implantable-defibrillator shocks by treatment with sotalol. d, l-Sotalol Implantable Cardioverter Defibrillator Study Group. N Engl J Med 1999;340: 1855–62. doi: 10.1056/NEJM199906173402402.

Dorian P, Borggrefe M, Al-Khalidi HR, et al. Placebo controlled, randomized clinical trial of azimilide for prevention of ventricular tachyarrhythmias in patients with an implantable cardioverter defibrillator. Circulation 2004;110: 3646–54. doi: 10.1161/01.CIR.0000149240.98971.A8

Ángel Arenal , Pablo Ávila , Javier Jiménez-Candil, et al. Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia J Am Coll Cardiol 2022 Apr 19;79(15):1441-1453. doi: 10.1016/j.jacc.2022.01.050

Reddy VY, Reynolds MR, Neuzil P, et al. Prophylactic catheter ablation for the prevention of defibrillator therapy. N Engl J Med. 2007;357(26): 2657–65. doi: 10.1056/NEJMoa065457

Amir AbdelWahab , John Sapp. Ventricular Tachycardia with ICD Shocks: When to Medicate and When to Ablate. Curr Cardiol Rep 2017 Sep 13;19(11):105 doi: 10.1007/s11886-017-0924-0

F. Streitner, J. Kuschyk, C. Dietrich, et al. Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention. Clin Cardiol, 34(10); (2011): 604-609 doi: 10.1002/clc.20949

Ihab Elsokkari, John L. Sapp. Electrical storm: Prognosis and management. Progress in Cardiovascular Diseases Volume 66, May–June 2021, Pages 70-79. doi: 10.1016/j.pcad.2021.06.007

Ahmed AlTurkia, Riccardo Proiettib, Vincenzo Russoc, et al. Anti-arrhythmic drug therapy in implantable cardioverter-defibrillator recipients. Pharmacological Research 2019 May;143: 133-142 doi: 10.1016/j.phrs.2019.03.020